Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center, Open Label Study to Assess the Safety and Tolerability of Metformin in Subjects With C9orf72 Amyotrophic Lateral Sclerosis Over 24 Weeks of Treatment

NCT04220021 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT04220021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04220021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center, Open Label Study to Assess the Safety and Tolerability of Metformin in Subjects With C9orf72 Amyotrophic Lateral Sclerosis Over 24 Weeks of Treatment
Lead sponsor
University of Florida
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 10, 2020
Completion date
August 31, 2027
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

c9orf72 amyotrophic lateral sclerosis (als), frontotemporal dementia